GENEVA, Aug. 21 -- ZHEJIANG CUIZE PHARMACEUTICAL TECHNOLOGY CO., LTD. filed a patent application (CN2026/078742) for “METHOD FOR TREATING POSTOPERATIVE PAIN AND USE THEREOF”. With publication no. WO/2... Read More
GENEVA, Aug. 21 -- ZHEJIANG CUIZE PHARMACEUTICAL TECHNOLOGY CO., LTD. filed a patent application (CN2026/078743) for “STABLE CRYSTAL OF ROPIVACAINE”. With publication no. WO/2026/171187, here are the ... Read More
GENEVA, Aug. 21 -- SHINING 3D TECH CO., LTD. filed a patent application (CN2026/078692) for “TRACKING SCANNER, TRACKING METHOD, TRACKING SCANNING SYSTEM AND STORAGE MEDIUM”. With publication no. WO/20... Read More
GENEVA, Aug. 21 -- SHINING 3D TECH CO., LTD. filed a patent application (CN2026/078693) for “TRACKING SCANNER”. With publication no. WO/2026/171182, here are the other details related to the patent ap... Read More
GENEVA, Aug. 21 -- FOSHAN WELLING WASHER MOTOR MANUFACTURING CO., LTD. filed a patent application (CN2026/078701) for “PUMP STRUCTURE AND WASHING DEVICE”. With publication no. WO/2026/171183, here are... Read More
GENEVA, Aug. 21 -- SENNICS CO., LTD. filed a patent application (CN2026/078601) for “RUBBER COMPOSITION AND USE THEREOF”. With publication no. WO/2026/171175, here are the other details related to the... Read More
GENEVA, Aug. 21 -- BEIJING TIANSHAN HI-TECH WIND POWER EQUIPMENT CO., LTD. filed a patent application (CN2026/078617) for “TOWER HOISTING METHOD, TOWER HOISTING TOOLING, TOWER, AND WIND TURBINE GENERA... Read More
GENEVA, Aug. 21 -- BEIJING GOLDWIND SCIENCE & CREATION WINDPOWER EQUIPMENT CO., LTD. filed a patent application (CN2026/078621) for “WIND FARM CONTROL METHOD AND APPARATUS”. With publication no. WO/20... Read More
GENEVA, Aug. 21 -- DUALITY BIOLOGICS (SHANGHAI) CO., LTD. filed a patent application (CN2026/078564) for “NMT INHIBITOR, INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF”. With public... Read More
GENEVA, Aug. 21 -- BEIJING TIDE PHARMACEUTICAL CO., LTD. filed a patent application (CN2026/078592) for “ATR KINASE INHIBITOR IN COMBINATION WITH ANTI-PD-1 ANTIBODY AND/OR ANTI-PD-L1 ANTIBODY TO TREAT... Read More